Overactivation of Signal Transducer and Activator of Transcription 3 in Canine Hepatocellular Carcinoma and Its Prognostic Significance
Authors:
Open Access
- 12 August 2024
- journal article
- research article
- Published by Wiley in Veterinary and Comparative Oncology
- Vol. 22 (4) , 490-499
Abstract
Phosphorylated signal transducer and activator of transcription 3 (pSTAT3), which is related to anti‐apoptosis, cellular proliferation, invasion and migration of tumours, has prognostic significance in malignant tumours in humans as well as in canine melanoma. However, the significance of pSTAT3 in canine liver tissues has not yet been evaluated. This study's objective was to compare its expression in canine normal, non‐neoplastic hepatic disease and hepatocellular carcinoma (HCC) tissues by immunohistochemical analysis. Furthermore, the association between pSTAT3 immunostaining and clinicopathological factors was investigated. Overall, 68 canine liver tissues, including 10 normal liver tissues, 30 non‐neoplastic hepatic disease tissues and 28 HCC tissues were examined, revealing distinct differences in pSTAT3 immunostaining among the groups. ( p < 0.001). Additionally, high pSTAT3 immunostaining was significantly associated with increased tumour size (5 > cm) ( p = 0.041), and metastasis ( p = 0.046). Furthermore, Kaplan–Meier survival curve analysis revealed a correlation between high pSTAT3 immunostaining and poor disease‐free survival ( p = 0.013) and overall survival ( p = 0.011). These findings suggest that overactivation of STAT3 is associated with poor prognosis in canine HCC. Therefore, pSTAT3 is considered a potential prognostic marker and therapeutic target for canine HCC.Keywords
This publication has 39 references indexed in Scilit:
- The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022ESMO Open, 2023
- Expression of Phosphorylated Signal Transducer and Activator of Transcription 3 and its Prognostic Significance in Canine Anal Sac AdenocarcinomaJournal of Comparative Pathology, 2021
- P-STAT3 and IL-17 in tumor tissues enhances the prognostic value of CEA and CA125 in patients with lung adenocarcinomaBiomedicine & Pharmacotherapy, 2020
- STAT3 isoforms: Alternative fates in cancer?Cytokine, 2019
- Overexpression of P-glycoprotein, STAT3, phospho-STAT3 and KIT in spontaneous canine cutaneous mast cell tumours before and after prednisolone treatmentThe Veterinary Journal, 2012
- Density of Gr1-positive myeloid precursor cells, p-STAT3 expression and gene expression pattern in canine mammary cancer metastasisVeterinary Research Communications, 2011
- Activation of signal transducer and activator of transcription 3 (Stat3) pathway in osteosarcoma cells and overexpression of phosphorylated‐Stat3 correlates with poor prognosisJournal of Orthopaedic Research, 2010
- Activation of STAT proteins and growth controlBioEssays, 2001
- The pathology of liver tumours in the dogJournal of Comparative Pathology, 1982
- Gross anatomy of the blood supply and biliary drainage of the canine liverThe Anatomical Record, 1970